Concepedia

John D. Klement

JD

24

Publications

1.6K

Citations

19

H-Index

2017

Active since

Affiliations

Augusta University(Current)

Charlie Norwood VA Medical Center

National Cancer Center of Georgia

Augusta University Health

Tianjin University

John D. Klement is an author at Augusta University specializing in cell biology, medicine, and immunology.

ORCID

Top concepts

Publications per year

2017–2023

24

Publications

24

An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion

John D. Klement, Amy V. Paschall, Priscilla S. Redd et al. · Journal of Clinical Investigation · 2018 · 359 citations · Full text

Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes

Chunwan Lu, John D. Klement, Mohammed L. Ibrahim et al. · Journal for ImmunoTherapy of Cancer · 2019 · 140 citations · Full text

Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis

Mohammed L. Ibrahim, John D. Klement, Chunwan Lu et al. · Cell Reports · 2018 · 122 citations · Full text

Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitment

John D. Klement, Priscilla S. Redd, Chunwan Lu et al. · Cancer Cell · 2023 · 111 citations · Full text

, , +18

Asah2 Represses the p53–Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis

Huabin Zhu, John D. Klement, Chunwan Lu et al. · The Journal of Immunology · 2021 · 107 citations · Full text

Rows per page

1–5 of 24